Comparison between the first and second generation bioresorbable vascular scaffolds: A six month virtual histology study

EuroIntervention

Volumn 6, Issue 9, 2011, Pages 1110-1116

  Brugaletta, Salvatore ^a   Garcia Garcia, Hector M ^a   Diletti, Roberto ^a   Gomez Lara, Josep ^a   Garg, Scot ^a   Onuma, Yoshinobu ^a   Shin, Eun Seok ^a   Van Geuns, Robert Jan ^a   De Bruyne, Bernard ^b   Dudek, Dariusz ^c   Thuesen, Leif ^d   Chevalier, Bernard ^e   McClean, Dougal ^f   Windecker, Stephan ^g   Whitbourn, Robert ^h   Dorange, Cecile ⁱ   Veldhof, Susan ⁱ   Rapoza, Richard ⁱ   Sudhir, Krishnankutty ⁱ   Bruining, Nico ^a   Ormiston, John A ^a   Serruys, Patrick W ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIOVASCULAR CENTER AALST   (Belgium)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^f CHRISTCHURCH HOSPITAL   (New Zealand)

^g UNIVERSITY OF BERN   (Switzerland)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ ABBOTT VASCULAR   (United States)

Author keywords

Bioresorbable vascular scaffold; Intravascular ultrasound virtual histology

Indexed keywords

CALCIUM; POLYLACTIDE; TISSUE SCAFFOLD; CARDIOVASCULAR AGENT; DRUG DERIVATIVE; EVEROLIMUS; POLYESTER; RAPAMYCIN;

ADULT; ARTICLE; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELASTIC TISSUE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; TISSUE NECROSIS; TISSUE STRUCTURE; VASCULAR TISSUE; VIRTUAL REALITY; AGED; ANGIOCARDIOGRAPHY; AUSTRALIA; CALCINOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; DRUG ELUTING STENT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EUROPE; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; NECROSIS; NEW ZEALAND; PROSTHESIS; RADIOGRAPHY; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; AUSTRALIA; CALCINOSIS; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; EUROPE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NECROSIS; NEW ZEALAND; POLYESTERS; PROSTHESIS DESIGN; SIROLIMUS; TIME FACTORS; TISSUE SCAFFOLDS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 80051644551     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I9A193     Document Type: Article

References (15)

1. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009; 373:897-910.
2. Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 2007;70:515-523. (Pubitemid 47597022)
3. Tanimoto S, Bruining N, van Domburg RT, Rotger D, Radeva P, Ligthart JM, Serruys PW. Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology. J Am Coll Cardiol 2008; 52:1616-1620.
4. Serruys PW, Onuma Y, Ormiston JA, De Bruyne B, Regar E, Dudek D, Thuesen L, Smith P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia Garcia HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis:6-month clinical and imaging outcomes. Circulation, 2010;122:2301-12.
5. Okamura T, Garg S, Gutierrez-Chico JL, Shin ES, Onuma Y, Garcia HM, Rapoza R, Sudhir K, Regar E, Serruys PW. In-vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: An OCT ad hoc analysis of the Revision 1.0 and Revision 1.1 stent design in the ABSORB clinical trial. EuroIntervention 2010;:932-938.
6. Kim SW, Mintz GS, Hong YJ, Pakala R, Park KS, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 2008; 102:1182-1186.
7. Garcia-Garcia HM, Gonzalo N, Pawar R, Kukreja N, Dudek D, Thuesen L, Ormiston JA, Regar E, Serruys PW. Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention 2009;4:443-448.
8. Sarno G, Onuma Y, Garcia Garcia HM, Garg S, Regar E, Thuesen L, Dudek D, Veldhof S, Dorange C, Ormiston JA, Serruys PW. IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process. Catheter Cardiovasc Interv. 2010;75:914-918.
9. Shin ES, Garcia-Garcia HM, Serruys PW. A new method to measure necrotic core and calcium content in coronary plaques using intravascular ultrasound radiofrequency-based analysis. Int J Cardiovasc Imaging 2010;26:387-396.
10. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-2206. (Pubitemid 35222213)
11. Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely JF, Murata A, Takeda Y, Ito T, Ehara M, Matsubara T, Terashima M, Suzuki T. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006;47:2405-2412. (Pubitemid 43866370)
12. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008; 371:899-907. (Pubitemid 351384734)
13. Ormiston JA, Webster MW, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv 2007;69:128-131. (Pubitemid 46052603)
14. Bruining N, de Winter S, Roelandt JR, Regar E, Heller I, van Domburg RT, Hamers R, Onuma Y, Dudek D, Webster MW, Thuesen L, Ormiston JA, Cheong WF, Miquel-Hebert K, Veldhof S, Serruys PW. Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. JACC Cardiovasc Interv. 2010;3:449-456.
15. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43. (Pubitemid 126426397)